Quick Answer
NeuroPace Inc reported Gross Profit of $77.22 million for the year ending 2025.
- NeuroPace Inc showed an increase of +30.7% in Gross Profit from 2024 to 2025.
- This data is from NeuroPace Inc's annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $7.06 million | Q2 2020: $5.42 million | Q3 2020: $9.58 million | Q1 2021: $8.49 million | Q2 2021: $9.36 million | Q3 2021: $7.51 million | Q1 2022: $8.26 million | Q2 2022: $7.47 million | Q3 2022: $7.97 million | Q1 2023: $10.37 million | Q2 2023: $11.97 million | Q3 2023: $12.23 million | Q1 2024: $13.34 million | Q2 2024: $14.13 million | Q3 2024: $15.42 million | Q1 2025: $17.34 million | Q2 2025: $18.13 million | Q3 2025: $21.17 million.
- Over the full 6 years of available data (2020 to 2025), NeuroPace Inc's Gross Profit has grown by 155.1%.
- Historical annual values: Fiscal year 2025: $77.22 million | Fiscal year 2024: $59.09 million | Fiscal year 2023: $48.12 million | Fiscal year 2022: $32.49 million | Fiscal year 2021: $33.44 million | Fiscal year 2020: $30.27 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: